You are here

personalized medicine

Current realities and reasonable expectations for sustainable personalized medicine

With the second wave of Covid-19 seeming, at that time, only a possible threat and not yet an actual scenario, four renowned experts from industry, academia, policymaking and clinical research gathered in a physical-virtual blended setting during the presentation of the BioRegion of Catalonia Life Sciences and Healthcare Outlook – Challenges ahead, at end of September, to shed light on the main questions about...

AB-Biotics i CompanionDX firmen l'acord
07.12.2015

The agreement signed with CompanionDX will bring the company at least €94,600 a month